Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $75.33.
A number of brokerages recently weighed in on NHI. Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target for the company. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price target for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Truist Financial decreased their price objective on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd.
View Our Latest Stock Analysis on NHI
Institutional Inflows and Outflows
National Health Investors Price Performance
Shares of National Health Investors stock opened at $67.24 on Tuesday. National Health Investors has a 1-year low of $51.59 and a 1-year high of $86.13. The firm’s 50-day moving average price is $73.44 and its two-hundred day moving average price is $75.87. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a market capitalization of $3.05 billion, a price-to-earnings ratio of 23.11, a P/E/G ratio of 4.86 and a beta of 1.06.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the prior year, the firm posted $1.08 EPS. National Health Investors’s revenue for the quarter was up 1.7% compared to the same quarter last year. On average, equities analysts predict that National Health Investors will post 4.42 earnings per share for the current fiscal year.
National Health Investors Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 5.35%. National Health Investors’s dividend payout ratio is presently 123.71%.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
- Five stocks we like better than National Health Investors
- Manufacturing Stocks Investing
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- How to Short a Stock in 5 Easy Steps
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Investing In Preferred Stock vs. Common Stock
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.